London, UK, 30 January 2012: BTG plc , the specialist healthcare company, today announces the successful outcome of VANISH-2, the first of two US pivotal Phase III studies comparing the safety and efficacy of Varisolve® (polidocanol endovenous microfoam (PEM)) with placebo in patients with symptomatic and visible varicose veins and saphenofemoral junction incompetence. Both pivotal Phase III [...]
Varicose Veins: BTG Announces Positive Data from First US Phase III Trial of Varisolve
http://dermatologistsblog.com/cosmetic-surgery/varicose-veins/varicose-veins-btg-announces-positive-data-from-first-us-phase-iii-trial-of-varisolve/
Study: Techniques to Treat Varicose Veins Appear Comparable in Effectiveness
CHICAGO—Endovenous laser treatment (EVLT) and high ligation and stripping (HLS) are both associated with effectiveness and safety in treatment of insufficiency of the great saphenous vein (GSV), but EVLT is more frequently associated with recurrences, according to a report published Online First by Archives of Dermatology, one of the JAMA/Archives journals. Prevalence rates of chronic [...]
http://dermatologistsblog.com/cosmetic-surgery/study-techniques-to-treat-varicose-veins-appear-comparable-in-effectiveness/



